Will Jin
LightNews LightNews
banner
wjin.bsky.social
Will Jin
@wjin.bsky.social
360 followers 210 following 46 posts
#radonc at University of Miami.
#Digitalhealth enjoyer. #digitaltransformation enthusiast.
Doesn’t have a podcast.
Posts Replies Media Videos
Reposted by Will Jin
jama.com
Viewpoint: Recent disruptions and funding cuts at the NIH undermine the infrastructure and stability of US scientific research, threatening the nation's global leadership and scientific productivity. https://ja.ma/3FLvqHS
American Science in Peril
This Viewpoint discusses the importance of federal funding of biomedical research from the National Institutes of Health to scientific discovery, advancements in individual and public health, and the support of the US’ community of scientists.
ja.ma
March 19, 2025 at 11:00 AM
Reposted by Will Jin
magdalenaskipper.bsky.social
How the NIH dominates the world’s health research — in charts (and what we stand to lose)
@nature.com @natureportfolio.nature.com
🧪

www.nature.com/articles/d41...
March 10, 2025 at 5:08 PM
Reposted by Will Jin
jdpereira.bsky.social
@nytimes.com the largest central of scientific knowledge in the world (Pubmed) and the NIH website is down.

I know it’s a tall ask but any insights?

These is largely taxpayer-funded research and it was available to all - and now it’s not.
March 2, 2025 at 12:40 AM
Reposted by Will Jin
altnih4science.bsky.social
Francis Collins, longtime NIH director with bipartisan bona fides*, retires as of yesterday.

He returned to NIH in 2023 to focus on research in his own lab, in the NIH in-house intramural research campus.

His letter seems to imply he wasn’t ready to leave. NIH is being torn down. 1/🧪 #academicsky
Statement by Francis Collins, MD. PhD March 1, 2025 Yesterday I notified NIH Acting Director Matt Memoli, MD of my retirement from the federal government. effective February 28, 2025. The National Institutes of Health is the world's foremost medical research institution. It has been rightfully called the "crown jewel" of the federal government for decades. It has been the greatest honor of my life to be part of this institution in various roles over the last four decades. In the 1980s, NIH supported my work at the University of Michigan through a peer-reviewed grant. That led to the identification of the gene for cystic fibrosis. Thirty years later that has led to an almost miraculous treatment that allows most kids with cystic fibrosis to look forward to an almost normal life span. I was recruited to NIH in 1993 to lead the Human Genome Project - an extraordinarily bold initiative to read out the three billion letters of the human DNA instruction book. Funded by the U.S. Congress, the project completed its work -- two years ahead of schedule, and $400 million under budget. The success of the project, and the commitment to share all of the data rapidly and freely, has revolutionized every aspect of human biomedical research and medical practice. Subsequently I was honored to be asked to serve as the Director of the National Institutes of Health. I had the chance to serve three Presidents - Barack Obama, Donald Trump, and Joseph Biden. I also had the opportunity to work regularly with members of Congress in both parties. I loved those interactions and relationships. Throughout that time, investment relieving human suffering, and contributing substantially to the U.S. economy. That consistent support made possible bold new projects in regenerative medicine, brain science, precision health, cancer, and solutions for opioid addiction, to name just a few. When the worst pandemic in more than a century arose in 2020, it was my job as Director of NIH to pull together partnerships with the FDA, academia, and the private sector to produce what only America's unparalleled biomedical sector could have: COVID vaccines in just 11 months, a staggering medical achievement that saved over three million lives in the U.S.alone. After a stint in the White House as the President's Acting Science Advisor, where I had the chance to organize a major initiative to eliminate hepatitis C in the United States, i returned to the intramural research program of the National Human Genome Research Institute in 2023. There I have been overseeing a research laboratory of a dozen highly talented and visionary scientists who are providing new insights into the causes and possible means of prevention of type 2 diabetes, as well as seeking a gene therapy cure for one of the world's rarest diseases - progeria, a premature aging disorder. NIH is the largest supporter of biomedical research in the world. It is the main piston of a biomedical discovery engine that is the envy of the globe. Yet it is not a household name. It should be. NIH supports everything from basic science to clinical trials, providing the foundation of many breakthroughs. When you hear about patients surviving stage 4 cancer because of immunotherapy, that was based on NIH research over many decades. When you hear about sickle cell disease being cured because of CRISPR gene editing, that was built on many years of research supported by NIH. It has also been the largest supporter of global health research in the world, winning us many friends and colleagues from across the globe. I have loved being employed by this extraordinary, life-giving institution for 32 years. I will continue to devote my life in other ways to seeking knowledge and enhancing health, to healing disease and reducing suffering, and to doing what I can to bring together our fractured communities around the shared values of love, truth, goodness, and faith. As I depart NIH, I want to express my gratitude and love for the men and women with whom I have worked side-by-side for so many years. They are individuals of extraordinary intellect and integrity, selfless and hard-working, generous and compassionate. They personify excellence in every way, and they deserve the utmost respect and support of all Americans.
March 1, 2025 at 3:25 PM
Reposted by Will Jin
nimasharifimd.bsky.social
More tragic news about NIH and NIH science. Grant system is frozen and intramural program is being slashed. All will claw back on treatments and cures for cancer and other human diseases. This can’t be what the public wants. 🧪 www.science.org/content/arti...
NIH ban on renewing senior scientists adds to assaults on its in-house research
Policy follows firings of tenure-track scientists and suspension of training programs
www.science.org
February 27, 2025 at 10:05 AM
Reposted by Will Jin
pkrugman.bsky.social
Today the CDC, tomorrow the BLS? paulkrugman.substack.com/p/lies-damne...
Lies, Damned Lies and Trumpflation
Big worries — and some investment advice
paulkrugman.substack.com
February 14, 2025 at 11:37 AM
Reposted by Will Jin
nytopinion.nytimes.com
JD Vance has expressed a “deep hostility to the entire academic enterprise, not just the so-called woke parts,” writes @michellegoldberg.bsky.social. "He wasn’t talking about making more room for right-wing ideas in universities or even dreaming of taking them over. He wanted to destroy it all."
Opinion | Trump Wants to Destroy All Academia, Not Just the Woke Parts
The administration’s war on universities defies rational self-interest.
www.nytimes.com
February 14, 2025 at 11:58 AM
Reposted by Will Jin
profajchalmers.bsky.social
Spectacular results! Consolidation #radiotherapy for gallbladder cancer improves survival and maintains quality of life.
Congratulations to the study team.
gawish.bsky.social Ahmed Gawish @gawish.bsky.social · Dec 14
The RACE-GB trial results are here! FIRST randomized controlled trial investigating radiotherapy (RT) in gallbladder cancer.

In a cohort of 135 patients the addition of RT after 4 cycles of chemotherapy (compared to observation) extended overall survival (OS) from 4 months to 10 months.@RadOnc
December 22, 2024 at 11:18 AM
Reposted by Will Jin
adesaimd.bsky.social
🔍 Does AI reduce #clinician workload?

@NEJM study on @NuanceDragon DAX Copilot, an AI-powered documentation tool, found minimal impact on EHR efficiency & financial metrics❗️

💡AI tools need to be developed in comjuction with 🩺🥼🧑‍⚕️ not in silos
#AIinMedicine #LLMs @oncoalert.bsky.social
December 21, 2024 at 5:17 AM
Reposted by Will Jin
mguckenberger.bsky.social
And yet another prospective trial confirming excellent efficacy of SBRT for localized HCC
- n=36 pts
- median tumor size 2.3 cm
- median FU 49 mo
- 3-year local control rate 93%
- Grade 3 AE 11%
www.redjournal.org/article/S036...
December 19, 2024 at 8:35 AM
wjin.bsky.social
oncodaily.com/blog/proton-...

We just treated our 1000th patient on our proton linac! #radonc
Celebrating the Treatment of Our 1000th Proton Therapy Patient - Sylvester Comprehensive Cancer Center - OncoDaily
Celebrating the Treatment of Our 1000th Proton Therapy Patient - Sylvester Comprehensive Cancer Center / cancer milestones, cancer treatment innovation, Keith
oncodaily.com
December 19, 2024 at 12:17 PM
Reposted by Will Jin
gawish.bsky.social
The RACE-GB trial results are here! FIRST randomized controlled trial investigating radiotherapy (RT) in gallbladder cancer.

In a cohort of 135 patients the addition of RT after 4 cycles of chemotherapy (compared to observation) extended overall survival (OS) from 4 months to 10 months.@RadOnc
December 14, 2024 at 4:31 PM
Reposted by Will Jin
nimasharifimd.bsky.social
The last session of the Miami Symposium on Human Metabolism will focus on approaches in metabolism, including mass spectrometry imaging and engineering! Speakers include Erin Seeley @utaustin.bsky.social, Jens Soltwisch and Ashutosh Agarwal! @asms.org Travel awards considered! miamimetabolism.com
December 17, 2024 at 12:23 PM
wjin.bsky.social
#medsky #radonc I’m about to go on paternity leave. What does parental leave look like at your institution? Did you take all of it? Did it impact your compensation? How did you mitigate loss of career momentum?
December 10, 2024 at 1:57 PM
Reposted by Will Jin
pkrugman.bsky.social
Sometimes the combination of arrogance and ignorance is breathtaking. Yes, US health care has high admin costs; that's because it relies so much on private insurers. Govt-run health insurance has much lower overhead
December 6, 2024 at 11:49 AM
Reposted by Will Jin
mguckenberger.bsky.social
Radiation Oncology is characterized by rapid innovation

Dissemination & implementation are important aspects to bring this progress to our cancer patients in daily practice

Well written review by Erin Gillespie and colleagues 👇
www.redjournal.org/article/S036...
DEFINE_ME
www.redjournal.org
December 7, 2024 at 9:32 AM
Reposted by Will Jin
freddyeescorcia.bsky.social
Systematic review & meta-analysis of locoregional therapies for #HCC in @jama.com network open

✅Inclusion:
RCTs with PFS and OS as endpoints

✅Conclusions:
Resection > thermal ablation ~ RT ~ HAIC > embolization

#oncsky #radonc #radsky #liversky

ja.ma/3ONRpQ1
Locoregional Therapies for Hepatocellular Carcinoma
This systematic review and meta-analysis compares findings from randomized clinical trials on the use of locoregional therapies as monotherapy or combination therapy in the treatment of nonmetastatic ...
ja.ma
December 6, 2024 at 12:45 PM
Reposted by Will Jin
drpeedell.bsky.social
Super proud of all my colleagues at James Cook University Hospital Cancer Centre who have now recruited 150 patients to the PACE-NODES trial! Huge amount of work and data collection involved. Let’s keep the momentum going. Massive thanks to all the patients. #PCSM #radonc #SBRT #SABR #NHS
December 5, 2024 at 8:36 PM
Reposted by Will Jin
ryanmarino.bsky.social
Private insurance defenders, do you really believe that 1/3 of healthcare claims are for unnecessary or fraudulent things?
December 4, 2024 at 9:35 PM
Reposted by Will Jin
weoncologists.bsky.social
The healthy pattern, marked by higher intake of fruits, vegetables, whole grains, and dairy, was associated with an 8% reduced GI cancer risk, while the unhealthy pattern, characterized by processed meats, alcohol, and sugary beverages, showed a 14% increased risk.
oncoalert.bsky.social The OncoAlert Network 🚨 @oncoalert.bsky.social · Dec 3
Difference in GI Cancer Risk & Mortality by Dietary Pattern Analysis

Assessed link between dietary patterns, derived using principal component analysis and reduced rank regression, and GI cancer risk and mortality.
https://buff.ly/3D1mcpS

@elisaagostinetto.bsky.social
@realbowtiedoc.bsky.social
December 3, 2024 at 10:36 PM
wjin.bsky.social
Vigilantism?
December 4, 2024 at 3:14 PM
Reposted by Will Jin
apccc.bsky.social
Study used 2sample Mendelian randomization approach to investigate the causal relationship between various dietary habits and #ProstateCancer risk

bmccancer.biomedcentral.com/articles/10....

@oncoalert.bsky.social
@drnataliagandur.bsky.social
@barbaramelao.bsky.social
@yukselurun.bsky.social
December 3, 2024 at 11:22 PM
wjin.bsky.social
#hcc
December 4, 2024 at 11:54 AM
Reposted by Will Jin
hemoncwarner.bsky.social
Our latest JCO CCI article by Vakili et al. explores AI’s role in cancer survivorship symptom monitoring using data from medical records and PROMs. A Herculean review of 18,530 articles to find 41 of relevance! ascopubs.org/doi/abs/10.1... @thelizarmy.bsky.social @emiliemgunn.bsky.social
Application of Artificial Intelligence in Symptom Monitoring in Adult Cancer Survivorship: A Systematic Review | JCO Clinical Cancer Informatics
PURPOSEThe adoption of artificial intelligence (AI) in health care may afford new avenues for personalized and patient-centered care. This systematic review explored the role of AI in symptom monitori...
ascopubs.org
December 3, 2024 at 3:33 PM